These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36935449)

  • 1. Inflammation Biomarker Response to Oral 2-Hydroxybenzylamine (2-HOBA) Acetate in Healthy Humans.
    Rathmacher JA; Fuller JC; Abumrad NN; Flynn CR
    Inflammation; 2023 Aug; 46(4):1343-1352. PubMed ID: 36935449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable device.
    O'Neill MJ; Yoneda ZT; Crawford DM; Ye F; Ao M; Pitchford LM; Rathmacher JA; Murray KT; Akers WS; Roden DM; Michaud GF; Shoemaker MB
    Trials; 2021 Aug; 22(1):576. PubMed ID: 34454591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.
    Davies SS; May-Zhang LS; Boutaud O; Amarnath V; Kirabo A; Harrison DG
    Pharmacol Ther; 2020 Jan; 205():107418. PubMed ID: 31629006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling.
    Shang L; Weng X; Wang D; Yue W; Mernaugh R; Amarnath V; Weir EK; Dudley SC; Xu Y; Hou M; Chen Y
    Free Radic Biol Med; 2019 Sep; 141():291-298. PubMed ID: 31254620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr
    Tao H; Huang J; Yancey PG; Yermalitsky V; Blakemore JL; Zhang Y; Ding L; Zagol-Ikapitte I; Ye F; Amarnath V; Boutaud O; Oates JA; Roberts LJ; Davies SS; Linton MF
    Nat Commun; 2020 Aug; 11(1):4084. PubMed ID: 32796843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophilic reactive aldehydes as a therapeutic target in colorectal cancer prevention and treatment.
    Gobert AP; Asim M; Smith TM; Williams KJ; Barry DP; Allaman MM; McNamara KM; Hawkins CV; Delgado AG; Zhao S; Piazuelo MB; Washington MK; Coburn LA; Rathmacher JA; Wilson KT
    Oncogene; 2023 May; 42(20):1685-1691. PubMed ID: 37037901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolevuglandins Scavenger Ameliorates Myocardial Ischemic Injury by Suppressing Oxidative Stress, Apoptosis, and Inflammation.
    Guo J; Xu F; Ji H; Jing Y; Shen L; Weng X; Hu L
    Front Cell Dev Biol; 2022; 10():836035. PubMed ID: 35356291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nutraceutical electrophile scavenger 2-hydroxybenzylamine (2-HOBA) attenuates gastric cancer development caused by Helicobacter pylori.
    Gobert AP; Asim M; Smith TM; Williams KJ; Barry DP; Allaman MM; McNamara KM; Hawkins CV; Delgado AG; Blanca Piazuelo M; Rathmacher JA; Wilson KT
    Biomed Pharmacother; 2023 Feb; 158():114092. PubMed ID: 36493697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Reactive Isolevuglandins Promote Atrial Fibrillation Caused by Hypertension.
    Prinsen JK; Kannankeril PJ; Sidorova TN; Yermalitskaya LV; Boutaud O; Zagol-Ikapitte I; Barnett JV; Murphy MB; Subati T; Stark JM; Christopher IL; Jafarian-Kerman SR; Saleh MA; Norlander AE; Loperena R; Atkinson JB; Fogo AB; Luther JM; Amarnath V; Davies SS; Kirabo A; Madhur MS; Harrison DG; Murray KT
    JACC Basic Transl Sci; 2020 Jun; 5(6):602-615. PubMed ID: 32613146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro safety pharmacology evaluation of 2-hydroxybenzylamine acetate.
    Fuller JC; Pitchford LM; Morrison RD; Daniels JS; Flynn CR; Abumrad NN; Oates JA; Boutaud O; Rathmacher JA
    Food Chem Toxicol; 2018 Nov; 121():541-548. PubMed ID: 30253245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes.
    Subati T; Yang Z; Murphy MB; Stark JM; Trykall DZ; Davies SS; Barnett JV; Murray KT
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and 28-day repeated dose toxicity evaluations of 2-hydroxybenzylamine acetate in mice and rats.
    Pitchford LM; Smith JD; Abumrad NN; Rathmacher JA; Fuller JC
    Regul Toxicol Pharmacol; 2018 Oct; 98():190-198. PubMed ID: 30075181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subchronic (90-day) repeated dose oral toxicity study of 2-hydroxybenzylamine acetate in rabbit.
    Fuller JC; Pitchford LM; Abumrad NN; Rathmacher JA
    Regul Toxicol Pharmacol; 2018 Dec; 100():52-58. PubMed ID: 30359704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial.
    Pitchford LM; Driver PM; Fuller JC; Akers WS; Abumrad NN; Amarnath V; Milne GL; Chen SC; Ye F; Roberts LJ; Shoemaker MB; Oates JA; Rathmacher JA; Boutaud O
    BMC Pharmacol Toxicol; 2020 Jan; 21(1):3. PubMed ID: 31907026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers.
    Pitchford LM; Rathmacher JA; Fuller JC; Daniels JS; Morrison RD; Akers WS; Abumrad NN; Amarnath V; Currey PM; Roberts LJ; Oates JA; Boutaud O
    BMC Pharmacol Toxicol; 2019 Jan; 20(1):1. PubMed ID: 30611293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicarbonyl Electrophiles Mediate Inflammation-Induced Gastrointestinal Carcinogenesis.
    Gobert AP; Boutaud O; Asim M; Zagol-Ikapitte IA; Delgado AG; Latour YL; Finley JL; Singh K; Verriere TG; Allaman MM; Barry DP; McNamara KM; Sierra JC; Amarnath V; Tantawy MN; Bimczok D; Piazuelo MB; Washington MK; Zhao S; Coburn LA; Wilson KT
    Gastroenterology; 2021 Mar; 160(4):1256-1268.e9. PubMed ID: 33189701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic (90-day) repeated dose toxicity study of 2-hydroxybenzylamine acetate in rats.
    Fuller JC; Pitchford LM; Abumrad NN; Rathmacher JA
    Regul Toxicol Pharmacol; 2018 Nov; 99():225-232. PubMed ID: 30266239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
    Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
    Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
    Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S
    Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus.
    Patrick DM; de la Visitación N; Krishnan J; Chen W; Ormseth MJ; Stein CM; Davies SS; Amarnath V; Crofford LJ; Williams JM; Zhao S; Smart CD; Dikalov S; Dikalova A; Xiao L; Van Beusecum JP; Ao M; Fogo AB; Kirabo A; Harrison DG
    JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35608913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.